CD47 and pancreatic adenocarcinoma: In summary, our analysis confirmed the role of 2 genes (CD47 and SCL44A1) in 2 cancer types (uterine corpus endometrial carcinoma and pancreatic adenocarcinoma, respectively) and highlighted 5 novel marker candidates in 6 cancer types (Figure 3).